| scholarly article | Q13442814 |
| P50 | author | Thomas Joseph Vogl | Q2427883 |
| Nagy N. Naguib | Q39984299 | ||
| Nour-Eldin A Nour-Eldin | Q43298035 | ||
| Tatjana Gruber-Rouh | Q102203484 | ||
| Stefan Zangos | Q117269933 | ||
| P2093 | author name string | Katrin Eichler | |
| P2860 | cites work | Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system | Q24530082 |
| New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 | ||
| Catheter replacement of the needle in percutaneous arteriography; a new technique | Q28208307 | ||
| Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial | Q29617955 | ||
| Liver metastases: interventional therapeutic techniques and results, state of the art. | Q30706589 | ||
| Breast cancer metastases in liver: laser-induced interstitial thermotherapy--local tumor control rate and survival data | Q30967346 | ||
| Liver Metastases: Neoadjuvant Downsizing with Transarterial Chemoembolization before Laser-Induced Thermotherapy | Q33193082 | ||
| Nonoperative ablation for liver metastases. Possibilities and limitations as a curative treatment | Q33215701 | ||
| Transcatheter and ablative therapeutic approaches for solid malignancies | Q33277802 | ||
| Metastasectomy as a cytoreductive strategy for treatment of isolated pulmonary and hepatic metastases from breast cancer | Q33961200 | ||
| Improved survival in resected biliary malignancies | Q34156918 | ||
| Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients | Q34569671 | ||
| Treatment for liver metastases from breast cancer: results and prognostic factors | Q35045527 | ||
| Chemoembolization in the Management of Liver Tumors | Q35552607 | ||
| Hepatectomy for metastatic noncolorectal gastrointestinal, breast and testicular tumours | Q36471612 | ||
| Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update | Q36582275 | ||
| Metastatic breast cancer: an updating | Q36584748 | ||
| Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors | Q39336459 | ||
| Prognostic factors for patients with liver metastases from breast cancer | Q46829269 | ||
| Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women | Q46831611 | ||
| Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients. | Q48829522 | ||
| Is liver resection justified for patients with hepatic metastases from breast cancer? | Q51775751 | ||
| Breast Liver Metastases – Incidence, Diagnosis and Outcome | Q55438353 | ||
| Hepatic Resection for Liver Metastases as Part of the “Oncosurgical” Treatment of Metastatic Breast Cancer | Q58860118 | ||
| Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy | Q61970363 | ||
| Resection or palliation: priority of surgery in the treatment of hilar cancer | Q69019418 | ||
| Clinical course of breast cancer patients with liver metastases | Q70337547 | ||
| Hepatectomy for liver metastases from breast cancer | Q71816280 | ||
| The regional treatment of liver metastases from breast cancer | Q72726906 | ||
| Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center | Q73441848 | ||
| Hepatic resection in metastatic breast cancer: results and prognostic factors | Q73616333 | ||
| Curative liver resection for metastatic breast cancer | Q73642112 | ||
| Surgical treatment of hepatic metastases from breast cancer | Q73806402 | ||
| Liver metastases of breast cancer: results of liver resection | Q77089555 | ||
| Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients | Q77535005 | ||
| Manifestations of metastatic tumors of the liver. A study of eighty-one patients subjected to needle biopsy | Q78834977 | ||
| Chemoembolization of liver metastasis from breast carcinoma | Q79793493 | ||
| [Liver metastases: incidence and histogenesis] | Q81342307 | ||
| Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies | Q82732610 | ||
| Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy | Q82732619 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 173-180 | |
| P577 | publication date | 2009-08-06 | |
| P1433 | published in | European Radiology | Q5413071 |
| P1476 | title | Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer | |
| P478 | volume | 20 |
| Q64285139 | 3D Printed Absorber for Capturing Chemotherapy Drugs before They Spread through the Body |
| Q55332855 | A Nomogram for Distinction and Potential Prediction of Liver Metastasis in Breast Cancer Patients. |
| Q24648677 | Ancient Greek and Greco-Roman methods in modern surgical treatment of cancer |
| Q26764990 | Arterial Therapies of Non-Colorectal Liver Metastases |
| Q51159127 | Doxorubicin-Loaded 70-150 μm Microspheres for Liver-Dominant Metastatic Breast Cancer: Results and Outcomes of a Pilot Study. |
| Q36076798 | Drug-eluting microspheres transarterial chemoembolization (DEM TACE) in patients with liver metastases. Pilot study. |
| Q33858454 | Follow-up study of liver metastasis from breast cancer treated by proton beam therapy |
| Q33587685 | Interventional procedures for hepatic metastases |
| Q47101871 | Intraarterial Liver-Directed Therapies: The Role of Interventional Oncology |
| Q88302050 | Locoregional Therapies for the Treatment of Hepatic Metastases from Breast and Gynecologic Cancers |
| Q36392298 | Metastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data |
| Q39455528 | Repetitive chemoembolization of hypovascular liver metastases from the most common primary sites |
| Q36310445 | Short-term effectiveness of radiochemoembolization for selected hepatic metastases with a combination protocol |
| Q34445101 | Thermal ablation therapies in patients with breast cancer liver metastases: a review |
| Q37808554 | Trans-arterial chemoembolization as a therapy for liver tumours: New clinical developments and suggestions for combination with angiogenesis inhibitors |
| Q37808643 | Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization? |
| Q84594473 | Treatment outcome of patients with liver-only metastases from breast cancer after mastectomy: a retrospective analysis |
Search more.